Live Ownership Coverage: Here is What Institutional Investors Think About Henry Schein Inc (NASDAQ:HSIC)

November 28, 2016 - By Hazel Jackson   ·   0 Comments

Live Ownership Coverage: Here is What Institutional Investors Think About Henry Schein Inc (NASDAQ:HSIC)

Sentiment for Henry Schein Inc (NASDAQ:HSIC)

Henry Schein Inc (NASDAQ:HSIC) institutional sentiment increased to 1 in 2016 Q2. Its up 0.08, from 0.92 in 2016Q1. The ratio improved, as 194 investment managers increased and opened new equity positions, while 212 cut down and sold stakes in Henry Schein Inc. The investment managers in our partner’s database now own: 74.55 million shares, down from 83.23 million shares in 2016Q1. Also, the number of investment managers holding Henry Schein Inc in their top 10 equity positions decreased from 15 to 12 for a decrease of 3. Sold All: 25 Reduced: 187 Increased: 150 New Position: 44.

Henry Schein, Inc. is a provider of health care services and products to office dental, animal health and medical practitioners. The company has a market cap of $11.97 billion. The Company’s divisions include healthcare distribution, and technology and value-added services. It has a 24.99 P/E ratio. The healthcare distribution segment aggregates its global dental, animal health and medical operating divisions.

About 395,256 shares traded hands. Henry Schein, Inc. (NASDAQ:HSIC) has declined 12.18% since April 25, 2016 and is downtrending. It has underperformed by 18.20% the S&P500.

Analysts await Henry Schein, Inc. (NASDAQ:HSIC) to report earnings on February, 8. They expect $1.84 EPS, up 10.18% or $0.17 from last year’s $1.67 per share. HSIC’s profit will be $146.36M for 20.45 P/E if the $1.84 EPS becomes a reality. After $1.68 actual EPS reported by Henry Schein, Inc. for the previous quarter, Wall Street now forecasts 9.52% EPS growth.

According to Zacks Investment Research, “Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets. The company conducts its business principally through two segments; healthcare distribution and technology. These segments, which are operated as individual business units, offer different products and services, albeit to the same customer base. The healthcare distribution segment consists of the company’s dental, medical, veterinary and international groups.”

North Point Portfolio Managers Corp Oh holds 3.91% of its portfolio in Henry Schein, Inc. for 112,325 shares. De Burlo Group Inc owns 87,420 shares or 3.74% of their US portfolio. Moreover, Alecta Pensionsforsakring Omsesidigt has 3.49% invested in the company for 2.02 million shares. The Switzerland-based Lombard Odier Asset Management (Switzerland) Sa has invested 3.36% in the stock. Waratah Capital Advisors Ltd., a Ontario – Canada-based fund reported 86,592 shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 0 insider buys, and 6 insider sales for $11.99 million net activity.

Henry Schein, Inc. (NASDAQ:HSIC) Ratings Coverage

Ratings analysis reveals 44% of Henry Schein Inc.’s analysts are positive. Out of 9 Wall Street analysts rating Henry Schein Inc., 4 give it “Buy”, 0 “Sell” rating, while 5 recommend “Hold”. The lowest target is $154 while the high is $170. The stock’s average target of $163.40 is 8.59% above today’s ($150.48) share price. HSIC was included in 10 notes of analysts from July 31, 2015. As per Thursday, November 5, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating by Bank of America given on Monday, September 12. UBS initiated Henry Schein, Inc. (NASDAQ:HSIC) on Thursday, October 6 with “Buy” rating. On Thursday, February 11 the stock rating was maintained by Piper Jaffray with “Neutral”. The stock of Henry Schein, Inc. (NASDAQ:HSIC) earned “Hold” rating by Gabelli on Friday, November 6. The rating was upgraded by Goldman Sachs on Tuesday, October 11 to “Buy”. The company was downgraded on Friday, July 31 by Evercore. Robert W. Baird downgraded it to “Neutral” rating and $164 target price in Friday, October 14 report.

HSIC Company Profile

Henry Schein, Inc., incorporated on December 23, 1992, is a well-known provider of health care services and products to office dental, animal health and medical practitioners. The Firm serves approximately one million clients across the world, including dental practitioners and laboratories, animal health clinics and physician practices, as well as government, institutional health care clinics and other alternate care clinics. The Company’s divisions include healthcare distribution, and technology and value-added services. The Firm operates through a distribution network with a selection of over 110,000 products and Henry Schein private brand products in stock, as well as approximately 150,000 additional products available as special order items. The Firm also offer its customers, technology solutions, including practice management software and e-commerce solutions, as well as a range of financial services.

More notable recent Henry Schein, Inc. (NASDAQ:HSIC) news were published by: Prnewswire.com which released: “Henry Schein Reports Record Third Quarter Financial Results” on November 02, 2016, also Prnewswire.com with their article: “Henry Schein Announces $400 Million Increase To Share Repurchase Plan” published on October 19, 2016, Forbes.com published: “Oversold Conditions For Henry Schein (HSIC)” on October 26, 2016. More interesting news about Henry Schein, Inc. (NASDAQ:HSIC) were released by: Newsday.com and their article: “Henry Schein CEO co-chairs new Muslim-Jewish Advisory Council” published on November 15, 2016 as well as Prnewswire.com‘s news article titled: “Henry Schein Reports Second Quarter Financial Results” with publication date: August 04, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Hazel Jackson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>